# Ranibizumab

## Lucentis inj 10mg/mL 0.165mL

| 藥物代碼           | ILUC3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Diabetic macular edema: Treatment of diabetic macular edema (DME).Diabetic retinopathy: Treatment of diabetic retinopathyMacular degeneration: Treatment of neovascular (wet) age-related macular degeneration (AMD)Macular edema: Treatment of macular edema following retinal vein occlusion (RVO)Myopic choroidal neovascularization: Treatment of myopic choroidal neovascularization (mCNV).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 副作用             | Nasopharyngitis, influenza; anemia; anxiety; headache, stroke; intraocular inflammation, vitritis, vitreous detachment, retinal hemorrhage, visual disturbance, eye pain, vitreous floaters, conjunctival hemorrhage, eye irritation, foreign body sensation in eyes, lacrimation increased, blepharitis, dry eye, ocular hyperemia, eye pruritus; retinal degeneration, retinal disorder, retinal detachment, retinal tear, detachment of retinal pigment epithelium, retinal pigment epithelium tear, visual acuity reduced, vitreous hemorrhage, vitreous disorder, uveitis, iritis, iridacyclitis, cataract, calaract subcapsular, posterior capsule opacification, punctuate keratitis, corneal abrasion, anterior chamber flare, vision blurred, inj site hemorrhage, eye hemorrhage, conjunctivitis, conjunctivitis allergic, eye discharge, photopsia, photophobia, ocular discomfort, eyelid edema, eyelid pain, conjunctival hyperemia; cough; nausea; allergic reactions; arthralgia; intraocular pressure increased.Common Ophthalmic: Cataract ( eovascular(wet) age-related macular degeneration 11% to 17%;macular edema following retinal vein occlusion,2%) , conjunctival hemorrhage (neovascular (wet) age- related macular degeneration 64% to 74%;macular edema following retinal vein occlusion, 48%) , Eye irritation (neovascular (wet) age- related macular degeneration 13% to 15% ; macular edema following retinal vein occlusion,7%) , Foreign body sensation, in the eyes (neovascular (wet) age- related macular degeneration 13% to 16%; macular edema following retinal vein occlusion, 7% to 16%) ,Inflammatory disorder of the eye (neovascular (wet) age- related macular degeneration 13% to 18% ), Pain in eye (neovascular (wet) age- related macular degeneration 26 % to 35% ; macular edema following retinal vein occlusion, 17% ), Raised intraocular pressure (neovascular (wet) age- related macular degeneration 17% to 24% ; macular edema following retinal vein occlusion,7% ) ,Visual disturbance (neovascular (wet) age- related macular degeneration 13% to 18% ; macular edema following retinal vein occlusion,5% ), Vitreous detachment (neovascular (wet) age- related macular degeneration 15% to 21% ; macular edema following retinal vein occlusion,4% ) , Vitreous floaters (neovascular (wet) age- related macular degeneration19 % to 27% ; macular edema following retinal vein occlusion, 7 %) |
| 禁忌               | Active or suspected ocular or periocular infections, active intraocular inflammation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 藥物保存方式       | 2-8℃                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 用法用量           | 0.5 mg (0.05 mL) by intravitreous inj, initiated with a loading phase of 1 inj/mth for 3 consecutive months followed by a maintenance phase in which patients should be monitored for visual acuity on a monthly basis. Interval between 2 doses should be > 1 month.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 孕期用藥建議       | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 附帶說明           | 仿單：1.預計懷孕的婦女：具生育能力的婦女於治療期間內須使用有效的避孕措施。 對於想懷孕的婦女，建議於施打最後一劑ranibizumab至少三個月後方進行懷孕。 2.目前尚無孕婦使用ranibizumab 的臨床資料。眼內注射ranibizumab 的全身暴露量較低，但是由於ranibizumab 的作用機轉，必須考慮其潛在造成致畸胎性 及對胎兒/ 胚胎發育不良影響的可能性。懷孕時不建議使用ranibizumab。 RANIBIZUMAB OPHTHALMIC Selective Vascular Endothelial Growth Factor Antagonist PREGNANCY RECOMMENDATION: Limited Human Data—Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 附帶說明           | 仿單：目前未知Lucentis 是否會分泌於人體乳汁中。為了小心起見，婦女在使用Lucentis 的治療期間不建議餵哺母乳。 RANIBIZUMAB OPHTHALMIC Selective Vascular Endothelial Growth Factor Antagonist BREASTFEEDING RECOMMENDATION: No Human Data—Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 注射劑給藥建議途徑 | IVI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 注意事項           | 1.Lucentis 必須由對玻璃體注射有經驗之合格的眼科醫生來使用。 2.建議劑量為一次在玻璃體內注射0.5 mg的Lucentis。注射至同一個眼球內的兩次劑量，至少需間 隔4 週。 3.曾經有Lucentis 與雷射光凝療法同時使用的經驗。在同一天施行治療時，應於雷射光凝療法完成後至少30 分鐘再施打Lucentis。                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

